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Dear Sirs,  
We commend Dr. Jinnah and colleagues for evaluating the reasons for unsatisfactory response to 
botulinum toxin (BoNT) in 35 patients with cervical dystonia (CD) [1]. They found that 
unsatisfactory outcomes were largely driven by suboptimal BoNT doses, wrong muscle targeting, 
and/or complex movement patterns [1]. Only one patient was functionally resistant to BoNT [1]. 
Notably, the majority of patients (about 78 %) receiving repeated injections reached a satisfactory 
response after adjusting BoNT dosing and/or muscle targets, indicating the final outcomes crucially 
relied on the involved physicians’ expertise [2]. Although their study was not designed to evaluate 
the role of polymyography, the authors do not support prior claims [3] that it might be useful to 
achieve optimal responses in these patients. Here, we wish to comment on the latter argument, 
providing novel data to suggest that use of polymyography is also important to obtain satisfactory 
responses to BoNT in these patients. As mentioned above, up to 78 % of patients receiving repeated 
injections had satisfactory responses following a mean number of 2 trials [1]. However, this could 
range from 1 to 8 trials [1]. Assuming a 3-month inter-trial interval, this implies that some patients 
had a satisfactory response only after 2 years. We can argue this would be on its own enough to 
warrant the use of the polymyography. Using such a technique would have likely reduced the time 
to achieve an optimal response, with obvious implications in terms of patients’ quality of life. 
Moreover, while we agree that in most patients the clinical pattern is indicative of the muscle 
targets, this is not always the case. We have collected information on 29 non-responder CD 
patients, referred to us to perform a polymyography (Table 1A). The clinical phenotype and details 
of muscle targets and BoNT dosages prior to the referral were gathered. All patients underwent an 
8-channel EMG recording as previously described [4], and 89.6 % (26/29) eventually achieved a 
satisfactory response. The remaining three had a predominant anterocollis likely with the 
involvement of (non-injectable) deep muscles of the neck, thus explaining the unresponsiveness (all 
three had a positive EDB test [5], ruling out functional resistance to BoNT). The main reasons for 
unresponsiveness are reported in Table 1B, selection of wrong muscles being the most common 
one. Worth noting, some of these patients were referred to us from clinicians with significant 
expertise in the field, thus highlighting the challenge of identifying the muscle targets on the basis 
of the clinical examination alone. This is supported by the fact that we failed to correlate the 
involvement of certain sets of muscles with specific phenotypes (data not shown), suggesting that 
different combinations of overactive muscles can give rise to similar phenotypes [4]. Additionally, 
we also found that in approximately 70 % of our patients, inappropriate injections were given into 
non-dystonic muscles (Fig. 1). It cannot be excluded that this was the case in a proportion of 
patients eventually having satisfactory responses in the work by Jinnah et al. This might further 
explain the discrepancy between their findings and ours, regarding low BoNT dosage as a reason 
for unresponsiveness. Sparing non-dystonic muscles might allow reducing the total BoNT dosage to 
use, further increasing the safety profile of the injections. Conversely, both studies are not suited to 
see whether a threshold between different BoNT dosages and the magnitude of the clinical response 
exists. Here, we wished to highlight the importance of the polymyography in the management of 
CD patients, apparently not responding to BoNT. We acknowledge that it is not widely available, 













Figure 1. Percentage of patients in whom muscle targets were missed (left panel) or wrongly 
injected (right panel)  
